At Deciphera, we’re driven by our mission to discover, develop, and deliver breakthrough medicines that have meaningful impact on patients. We are determined to listen to and understand patient experiences so we can best discover, develop, and deliver new medicines to the people for whom there is high unmet need. We work hand-in-hand with patients, caregivers, and advocacy groups to drive clinical breakthroughs, shape access strategies, and create support programs that reflect varying perspectives and real-world experiences.
“Deciphera is committed to meet the challenge of defeating disease by fostering inclusive, trust-based partnerships with the global patient communities we serve.”
- Deciphera Patient Advocacy Team
Through grants, sponsorships and research opportunities, Deciphera is committed to our patients, caregivers, advocacy groups, healthcare providers (HCPs) and researchers.
Please send all submissions and inquires to patientadvocacygrants@deciphera.com
For more information about the diseases we target, please visit our Pipeline page.
Deciphera may be able to provide access to an investigational medicine, under certain limited conditions, through our Expanded Access Program (EAP)
Advocacy organizations provide resources, information, and connections to other patients and members of the cancer community. If you are an individual, family member, or caregiver affected by GIST, TGCT, PCNSL or another cancer, consider visiting the below independently affiliated resources.
We want to hear from you. Email patientadvocacy@deciphera.com
if you would like to share your story of living with GIST, TGCT or PNSCL.

















